Innospec sets a 52-week high and Innospec stock gains 2.65 percent
Innospec (IOSP) stock reached a new 52-week high of USD 100.48 and gained 2.65 percent, trading at EUR 87.00. The specialty chemicals company reported strong Q2 2026 revenues of USD 491.40 million, surpassing expectations, with adjusted earnings per share also beating consensus estimates. Analysts maintain a "Buy" rating with a price target of USD 110.00, indicating further potential upside.
Avient Advances Circularity by Launching Nymax FR REC Flame Retardant
Avient has launched Nymax FR REC flame-retardant recycled polyamide grades to meet the increasing demand for sustainable materials, particularly in electrification and circularity initiatives. These new grades offer non-halogenated fire safety and contain 42-77% post-industrial recycled content, aligning with global electrical safety standards and regulatory requirements. The company, along with peers like Innospec, Quaker Chemical, and Cabot, is focusing on sustainability and growth, with Avient raising its full-year 2026 adjusted earnings guidance.
Innospec Inc stock hits 52-week high at 97.2 USD By Investing.com
Innospec Inc. (IOSP) has reached a 52-week high of $97.2, reflecting strong performance with a 44% gain over six months and a 24.1% increase over one year. InvestingPro analysis indicates the stock is undervalued, and the company has a "GOOD" financial health score, actively buying back shares and consistently raising dividends for 12 consecutive years. This milestone follows better-than-expected Q2 2026 earnings, with adjusted EPS at $1.27 and revenue at $491.4 million, surpassing analyst predictions.
Innospec Inc stock hits 52-week high at 97.2 USD By Investing.com
Innospec Inc. (IOSP) has reached a 52-week stock high of $97.2, reflecting strong performance and investor confidence. The company's stock has seen a 44% gain over six months and a 24.1% increase in a year, currently trading at $95.98. InvestingPro analysis indicates the stock is undervalued, and the company has consistently raised dividends for 12 consecutive years, alongside recent better-than-expected Q2 2026 earnings.
Innospec stock trades near 52-week high after strong Q2 beat
Innospec stock is trading near its 52-week high after reporting a strong Q2 2026 earnings beat, with adjusted EPS of $1.27 against a $1.05 consensus and revenue of $491.4 million, exceeding forecasts. While revenue grew significantly, operating cash flow for the first half of 2026 decreased due to changes in working capital, posing a question for investors about future cash generation despite the robust profit results. The stock closed at $96.60 on Nasdaq, just 0.6% below its yearly peak.
Innospec Inc stock hits 52-week high at 97.2 USD
Innospec Inc. (IOSP) has reached a new 52-week high of $97.2, reflecting strong performance with 44% gains over six months and 24.1% over one year. InvestingPro analysis indicates the stock is undervalued with "GOOD" financial health, and the company has consistently raised dividends for 12 years. This milestone follows better-than-expected Q2 2026 financial results, where adjusted EPS surpassed projections by 21% and revenue by 6.4%.
Innospec Inc. (IOSP) Stock Price, News, Quote & History
This article provides a comprehensive overview of Innospec Inc. (IOSP), a specialty chemicals company, including its current stock price, market data, and company profile. It details the company's financial performance, analyst ratings, and key statistics, offering investors a snapshot of its market position and operational segments.
Innospec Inc. - Common Stock (NQ: IOSP)
This page provides the latest news and financial updates for Innospec Inc. (IOSP), including its stock performance and earnings reports. Recent headlines highlight the company's Q1 and Q2 2024 earnings, where it beat EPS estimates but missed revenue targets, alongside older news regarding volatility and previous earnings insights. The stock is currently trading at $98.11, up 1.27%.
Avoiding Lag: Real-Time Signals in (IOSP) Movement
Innospec Inc. (NASDAQ: IOSP) is showing neutral near and mid-term readings but maintains a long-term positive bias, with resistance currently being tested. AI models have generated specific trading strategies, including long position, momentum breakout, and short risk-hedging strategies, targeting different risk profiles. The analysis highlights key support and resistance levels across multiple timeframes, emphasizing an exceptional 26.9:1 risk-reward short setup.
Innospec secures the win for the Regulatory & Compliance Excellence category in the Cosmetics Business Innovation Awards
Innospec has won the Regulatory & Compliance Excellence category at the first-ever Cosmetics Business Innovation Awards. The company was recognized for its novel human-focused methodologies to test the safety of cosmetic ingredients, providing an ethical alternative to animal testing. Judge Emma Meredith praised Innospec's commitment to advancing regulatory acceptance of non-animal alternative methods, which could lead to significant industry-wide change.
Innospec stock hits 52-week high at 95.07 USD
Innospec Inc. (IOSP) has reached a 52-week stock price high of $95.07, demonstrating significant growth with a 24.73% year-to-date return and a 7.73% increase over the past year. This milestone follows strong Q2 2026 financial results where the company surpassed earnings and revenue expectations. InvestingPro analysis suggests the stock is currently undervalued, highlighting its 12-year dividend growth and aggressive share buyback program.
Innospec Inc (OCT) Q1 2024 Earnings Report - Results, Call & Slides
Innospec Inc. (OCT) reported its Q1 2024 earnings, beating the consensus EPS by €0.10 with an actual EPS of €1.51 against a consensus of €1.42. However, the company missed revenue expectations, posting €432.90M against an expected €436.31M, marking a year-over-year revenue growth decline of 1.84%. The earnings call was held on May 9, 2024, and the next earnings report is estimated for November 10, 2026.
Innospec Inc (OCT) Q2 2023 Earnings Report - Results, Call & Slides
This article provides an overview of Innospec Inc.'s (OCT) Q2 2023 earnings report. The company met EPS expectations at €1.11 but missed revenue projections by €13.47 million, reporting €415.77 million against an expected €429.24 million, despite a 2.74% year-over-year revenue growth. The report also includes details on the earnings call, slide deck, and historical earnings data, with the next earnings date estimated for November 10, 2026.
What Innospec (IOSP)'s Strong Q2 Earnings and Completed Buyback Mean For Shareholders
Innospec Inc. (IOSP) reported strong second-quarter 2026 earnings with increased sales and net income, alongside the completion of a US$34.87 million share repurchase program. While these results show improved financial health and a commitment to returning cash to shareholders, the long-term investment narrative remains focused on managing raw material volatility in Performance Chemicals and the potential risks to Fuel Specialties from shifts in transportation fuels. Analysts project future revenue and earnings growth, with a fair value estimate providing a modest upside, but also highlight varied community fair value estimates and ongoing margin pressure as key considerations for investors.
Innospec (IOSP) Could Be 6% Undervalued After Strong First Half Results
Innospec (IOSP) reported strong first-half 2026 results with increased sales and net income, alongside ongoing share repurchase activities. Despite an 11.39% 30-day share
What Innospec (IOSP)'s Strong Q2 Earnings and Completed Buyback Mean For Shareholders
Innospec Inc. (IOSP) reported strong Q2 2026 earnings with increased sales and net income, alongside completing a $34.87 million share repurchase program. The company's investment narrative focuses on turning specialized chemicals into consistent earnings despite raw material volatility and shifts in transportation fuels. Forecasts project significant revenue and earnings growth by 2029, suggesting a fair value upside for shareholders.
Innospec Inc (0JAX) Q1 2026 Earnings Report - Results, Call & Slides
Innospec Inc (0JAX) reported its Q1 2026 earnings, beating both EPS and revenue expectations. The company posted an actual EPS of $1.05 against a consensus of $1.01, and actual revenue of $453.20M compared to an expected $432.14M, representing a 2.81% year-over-year revenue growth. Innospec's next earnings report is estimated for November 10, 2026.
Innospec Inc (0JAX) Q1 2024 Earnings Report - Results, Call & Slides
This article details Innospec Inc.'s (0JAX) Q1 2024 earnings report, revealing an EPS beat at $1.75 against a consensus of $1.64, while revenue of $500.20M missed expectations slightly. It includes information on the earnings call, slide deck availability, and historical earnings data, alongside estimated future earnings dates.
Innospec stock hits 52-week high at 94.67 USD By Investing.com
Innospec Inc. (IOSP) stock reached a new 52-week high of $94.67, driven by strong performance and investor confidence, with a year-to-date return of 23% in 2026. The specialty chemicals company reported impressive Q2 2026 financial results, exceeding earnings and revenue expectations despite facing near-term supply constraints. InvestingPro analysis suggests the stock, with a market capitalization of $2.31 billion and a P/E ratio of 19.08, may still be undervalued.
Innospec stock hits 52-week high at 94.67 USD
Innospec Inc. (IOSP) stock has reached a new 52-week high of $94.67, driven by strong performance including a 12.15% gain over the past year and a 23% year-to-date return in 2026. This milestone follows impressive Q2 2026 financial results, where the company surpassed earnings and revenue expectations despite facing near-term supply constraints and mixed margin trends. InvestingPro analysis suggests the stock may be undervalued with a P/E ratio of 19.08.
Innospec stock hits 52-week high at 94.67 USD By Investing.com
Innospec Inc. (IOSP) stock has reached a new 52-week high of $94.67, driven by strong financial performance including adjusted earnings of $1.27 per share and revenues of $491.4 million in Q2 2026, both exceeding analyst expectations. The specialty chemicals company, with a market capitalization of $2.31 billion and a P/E ratio of 19.08, has seen a 12.15% increase over the past year and a 23% year-to-date return in 2026, though it faces near-term supply constraints and mixed margin trends.
Innospec stock hits 52-week high at 94.67 USD By Investing.com
Innospec Inc. (IOSP) stock reached a new 52-week high of $94.67, driven by strong Q2 2026 financial results that surpassed analyst expectations for both earnings and revenue. The specialty chemicals company boasts a market capitalization of $2.31 billion and a P/E ratio of 19.08, with its stock up 23% year-to-date in 2026. Despite positive performance, investors are monitoring near-term supply constraints and mixed margin trends.
Trading Systems Reacting to (IOSP) Volatility
This article analyzes Innospec Inc. (NASDAQ: IOSP) using AI models to generate trading strategies and signals. It identifies strong near and mid-term sentiment, potential upside, and provides specific long, breakout, and short strategies with entry, target, and stop-loss zones. The analysis also includes multi-timeframe signal strengths, support, and resistance levels for IOSP.
Innospec (IOSP) Is Up 7.5% After Debt-Free, Higher-Margin Q2 2026 Earnings Report – What’s Changed?
Innospec (IOSP) reported strong Q2 2026 results with sales rising to US$491.4 million and net income to US$30.8 million, driven by improved earnings and a debt-free balance sheet. This performance, coupled with a US$75 million share repurchase authorization, reinforces the company's financial flexibility, though risks like margin pressure in Performance Chemicals and softer Oilfield Services demand remain. The article discusses Innospec's investment narrative, fair value estimates, and key considerations for investors, highlighting its projected revenue of $2.2 billion and earnings of $167.5 million by 2029.
Assenagon Asset Management S.A. Sells 218,102 Shares of Innospec Inc. $IOSP
Assenagon Asset Management S.A. reduced its stake in Innospec Inc. (NASDAQ:IOSP) by 44.4% in the second quarter, selling 218,102 shares and retaining 272,782 shares valued at approximately $22.2 million. Despite this reduction, institutional investors collectively own 96.64% of the company. Innospec recently exceeded quarterly expectations with $1.27 EPS and $491.4 million in revenue, leading to improved analyst sentiment with some "Buy" ratings and a consensus "Hold."
Innospec (IOSP) Is Up 7.5% After Debt-Free, Higher-Margin Q2 2026 Earnings Report – What’s Changed?
Innospec (IOSP) reported strong Q2 2026 results with sales rising to US$491.4 million and net income to US$30.8 million, leading to a 7.5% stock increase. The company achieved a debt-free balance sheet and authorized a US$75 million share repurchase. Despite positive earnings, risks like margin pressure in Performance Chemicals and softer Oilfield Services demand remain key factors for future performance.
Innospec Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:IOSP) 2026-08-08
Innospec Inc. (IOSP) has published its Q2 2026 earnings call presentation, detailing its financial results for the quarter. The company reported an EPS of $1.27, surpassing estimates by $0.22, and revenue of $491.40 million, which beat expectations by $34.17 million and represents an 11.76% year-over-year increase. This article provides access to the slide deck presented during the earnings call.
IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth
Innospec Inc. (IOSP) reported strong second-quarter 2026 results, with adjusted earnings of $1.27 per share and revenues of $491.4 million, both surpassing Zacks Consensus Estimates. The growth was broad-based across its Performance Chemicals, Fuel Specialties, and Oilfield Services segments. The company also highlighted its debt-free position, semi-annual dividend payment, and share repurchases, with management anticipating further improvements in the second half of the year.
Public Employees Retirement System of Ohio Reduces Holdings in Innospec Inc. $IOSP
The Public Employees Retirement System of Ohio significantly reduced its stake in Innospec Inc. (NASDAQ:IOSP) by 96.6% in the first quarter, now holding only 687 shares valued at $50,000. Despite this reduction, Innospec reported strong quarterly earnings, beating analyst estimates with $1.27 EPS and revenue of $491.4 million. The company's stock is trading near its 52-week high, and while the overall analyst sentiment is "Hold," some firms like Seaport Research Partners maintain a "Buy" rating.
Innospec Inc (IOSP) (Q2 2026) Earnings Call Highlights: Strong Growth Across All Segments, but ...
Innospec Inc. (IOSP) reported strong Q2 2026 earnings with double-digit sales and operating income growth across all segments, driven by effective pricing and demand in Oilfield Services. Despite this, the company faced slight gross margin decreases in Performance Chemicals and Fuel Specialties due to supply constraints, weaker sales mix, and pricing lag. Management addressed facility repairs, capacity expansion, and growth drivers in the drag reducing agent (DRA) business, expecting additional capacity benefits in late Q4 2026 or Q1 2027.
Innospec Inc. $IOSP Shares Sold by Janus Henderson Group PLC
Janus Henderson Group PLC reduced its stake in Innospec Inc. (NASDAQ:IOSP) by 11.7% in the first quarter, selling 17,579 shares but retaining 133,272 shares valued at approximately $9.7 million. Despite this, other major institutional investors like Assenagon Asset Management, Western Standard, Goldman Sachs, and Millennium Management significantly increased their positions. Innospec reported strong quarterly earnings of $1.27 EPS, beating estimates by $0.22, and an 11.8% year-over-year revenue increase to $491.4 million, yet analysts maintain an overall "Hold" rating for the stock which is trading near its 52-week high.
Arrowstreet Capital Limited Partnership Boosts Holdings in Innospec Inc. $IOSP
Arrowstreet Capital Limited Partnership significantly increased its stake in Innospec Inc. (NASDAQ:IOSP) by 196.5% in the first quarter, bringing its total holdings to 18,497 shares valued at $1.35 million. This move is part of a broader trend of institutional investors, who collectively own 96.64% of IOSP, adding to their positions. Innospec recently reported strong quarterly earnings of $1.27 per share, surpassing estimates, with revenue climbing 11.8% year over year to $491.4 million, contributing to the stock trading near its 12-month high.
Innospec Inc (IOSP) (Q2 2026) Earnings Call Highlights: Strong Growth Across All Segments, but ...
Innospec Inc. (IOSP) reported strong Q2 2026 earnings with double-digit sales and operating income growth across all segments, including significant gains in Performance Chemicals and Oilfield Services. Despite this, the company faced some challenges such as slightly decreased gross margins in Performance Chemicals and Fuel Specialties, largely due to supply constraints and sales mix issues. Management outlined plans for facility repairs and expansions expected to boost capacity and efficiency by late Q4 2026 or Q1 2027, expressing confidence in future growth while acknowledging near-term capacity limitations and margin pressures.
Innospec (NASDAQ: IOSP) grows Q2 2026 revenue 12% to $491.4M
Innospec Inc. reported strong Q2 2026 financial results with total revenue increasing 12% to $491.4 million, driven by broad-based growth across all segments. Net income attributable to Innospec rose to $30.8 million, and diluted GAAP EPS increased to $1.25. The company maintained a debt-free balance sheet with $250.2 million in cash and returned capital to shareholders through dividends and share repurchases.
Innospec Inc stock hits 52-week high at $92.31
Innospec Inc (IOSP) stock has reached a new 52-week high of $92.31, reflecting a 15.73% increase over the past year. InvestingPro analysis suggests the stock is currently undervalued. This milestone follows the company's strong Q2 2026 results, where adjusted earnings and revenue surpassed analyst expectations.
Innospec Inc stock hits 52-week high at $92.31 By Investing.com
Innospec Inc. (IOSP) stock reached a new 52-week high of $92.31, with a current market capitalization of $2.26 billion and a 15.73% increase over the past year. InvestingPro analysis suggests the stock is undervalued, and the company recently reported strong Q2 2026 results, surpassing analyst expectations with adjusted EPS of $1.27 and revenue of $491.4 million.
INNOSPEC INC. Q2 2026: Revenue $491.4M, EPS $1.25— 10-Q Summary
Innospec Inc. reported strong second-quarter 2026 results, with revenue reaching $491.4 million and diluted EPS at $1.25, significantly up from the previous year. This growth was fueled by volume and mix gains across all segments, particularly Fuel Specialties and Performance Chemicals, and increased demand for higher-margin products. The company also saw improvements in net income and made operational progress, including plant expansion and ERP implementation, though adjusted working capital rose due to inventory increases.
Earnings call transcript: Innospec tops Q2 2026 forecasts as shares rise
Innospec Inc. reported stronger-than-expected second-quarter 2026 results, with adjusted EPS of $1.27 and revenue of $491.4 million, surpassing Wall Street forecasts. The company's stock rose 2.7% following the announcement, driven by double-digit growth across all business segments and a debt-free balance sheet. Management highlighted ongoing plant repairs in Performance Chemicals, expected to increase capacity by over 10% by early 2027, and continued strong performance in Fuel Specialties and Oilfield Services.
Innospec Q2 2026 Earnings Call Transcript
Innospec reported a strong Q2 2026 with a 12% revenue increase to $491.4 million and net income up to $30.8 million. Performance Chemicals and Oilfield Services drove operating income growth, with Performance Chemicals plant repairs expected to increase capacity by over 10% by late Q4 2026 or early 2027. Fuel Specialties also saw revenue growth, though operating income growth was more modest due to sales mix and pricing lags, with management anticipating continued strong performance despite some Q3 margin pressure.
Earnings Flash (IOSP) Innospec Inc. Posts Q2 Adjusted EPS $1.27 per Share, Vs. FactSet Est of $1.05
Innospec Inc. (IOSP) announced its Q2 adjusted EPS of $1.27 per share, significantly surpassing the FactSet estimate of $1.05 per share. This indicates a strong financial performance for the company during the second quarter.
Innospec Reports Second Quarter 2026 Financial Results
Innospec Inc. announced strong financial results for the second quarter of 2026, with revenues up 12% to $491.4 million and operating income increasing by 16%. The company reported GAAP EPS of $1.25 and adjusted non-GAAP EPS of $1.27, driven by robust contributions from all business segments, particularly Fuel Specialties, Performance Chemicals, and Oilfield Services. Innospec maintained a debt-free balance sheet with over $250 million in net cash and returned value to shareholders through dividends and share repurchases.
Innospec Inc reports results for the quarter ended June 30 - Earnings Summary
Innospec Inc. has released its earnings summary for the quarter that ended on June 30. The full article, provided by Refinitiv, is available through TradingView for subscribers.
Earnings Flash (IOSP) Innospec Inc. Posts Q2 Adjusted EPS $1.27 per Share, vs. FactSet Est of $1.05
Innospec Inc. (IOSP) announced Q2 adjusted EPS of $1.27 per share, surpassing FactSet's estimate of $1.05. The company also reported Q2 revenue of $491.4 million, exceeding FactSet's estimate of $457.2 million. These results indicate a strong financial performance for Innospec Inc. in the second quarter of 2026.
Press Release: Innospec Reports Second Quarter 2026 Financial Results
This is a press release announcing Innospec's financial results for the second quarter of 2026. The document is the full press release content which would typically include detailed financial figures, commentary from management, and future outlook.
Allspring Global Investments (IOSP) discloses 7.7% beneficial stake in Innospec
Allspring Global Investments Holdings, LLC has disclosed a 7.7% beneficial ownership stake in Innospec Inc. (IOSP) through an amended Schedule 13G filing. This represents 1,892,471 shares, with Allspring holding sole voting power over 1,891,583 shares and sole dispositive power over all 1,892,471 shares. No single client of Allspring's investment advisers holds more than five percent of Innospec's common stock.
How Innospec Inc. (IOSP) Affects Rotational Strategy Timing
This article analyzes Innospec Inc. (IOSP) using AI models to provide trading strategies for different risk profiles. It highlights strong near and mid-term sentiment, tests of resistance levels, and offers specific long, breakout, and short trading setups with defined targets and stop losses. The analysis also includes multi-timeframe signal strengths, support, and resistance levels for IOSP.
How Investors May Respond To Innospec (IOSP) Earnings Decline Expectations Amid Rising Revenue
Innospec (IOSP) is facing expectations of a year-over-year earnings decline for June 2026, despite projected revenue increases, with a negative Earnings ESP suggesting an earnings miss. This situation puts pressure on management to address margin profitability, especially following its recent removal from several Russell indices. The article highlights that Innospec's narrative projects significant revenue and earnings growth by 2029, with fair value estimates suggesting a potential upside, though investors should consider the risk of sustained margin pressure.
Innospec Inc (IOSP) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis for Innospec Inc (IOSP), noting its current valuation score of 6.12, ranking 59 out of 65 in the Chemicals industry. It highlights the company's current P/E ratio of 18.69 and mentions that relevant data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company.
Innospec Inc (IOSP) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Innospec Inc (IOSP), noting its current risk assessment score of 8.57, which ranks it 12th out of 65 in the Chemicals industry. The assessment highlights the company's beta value of 0.90, indicating less volatility than the overall market. It also details various risk metrics including maximum drawdown, volatility, Sharpe ratio, and liquidity.
IOSP|Innospec Inc|Price:84.875|Chg%:-1.025
Innospec Inc. (IOSP) is trading at $84.875, down 1.19%, with a market cap of $2.10 billion. The company's fundamentals are strong, and its valuation is considered fair within the Chemicals industry. Analysts have rated it "Buy" with a target price of $99.33.
